Daniel Pharand has been appointed executive VP business development of PanGeo Pharma Inc, a Montreal-based contract manufacturer providing formulation development and sale distribution services to multinational drug firms. Pharand is also VP health sciences at Innovatech du Grand Montréal, a venture capital firm and an investor in PanGeo. He represents Innovatech on the boards of eight investee firms active in the health sector. Prior to joining Innovatech, Pharand was with Price Waterhouse and then Sweden’s Pharmacia, a multinational firm specializing in biotechnology and pharmaceuticals....